Who
Frederick W. Ahlholm
SVP, CFO and Secretary
Company insider
Files Form 4 as: SVP, CFO and Secretary, Minerva Neurosciences; Vice President Finance, Amarin Corporation.
In numbers
- Trades disclosed
- 49
- Buys
- 1
- Sells
- 10
- Bought
- $60K
- Sold
- $1.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 4 Apr 2011
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —680,000 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —680,000 at $0.00 | filing |
| 22 Dec 2025filed 23 Dec 2025 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 5 Dec 2024filed 6 Dec 2024 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,500 at $0.00 | filing |
| 4 Oct 2023filed 5 Oct 2023 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,850 at $0.00 | filing |
| 1 May 2023filed 2 May 2023 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $16K3,580 at $4.48 | filing |
| 28 Apr 2023filed 2 May 2023 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Code A | —19,843 at $0.00 | filing |
| 13 Dec 2022filed 14 Dec 2022 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,000 at $0.00 | filing |
| 16 Feb 2022filed 18 Feb 2022 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 16 Dec 2020filed 16 Dec 2020 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $4,8711,845 at $2.64 | filing |
| 14 Dec 2020filed 16 Dec 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 14 Dec 2020filed 16 Dec 2020 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Code M | —5,000 | filing |
| 13 Oct 2020filed 14 Oct 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —85,000 at $0.00 | filing |
| 19 Jun 2020filed 17 Aug 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —137,784 at $0.00 | filing |
| 26 May 2020filed 27 May 2020 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $125K8,339 at $15.00 | filing |
| 31 Dec 2019filed 3 Jan 2020 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,216 at $0.00 | filing |
| 17 Dec 2019filed 17 Dec 2019 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $11K1,557 at $7.10 | filing |
| 14 Dec 2019filed 17 Dec 2019 | NERV Minerva Neurosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,000 at $0.00 | filing |
| 14 Dec 2019filed 17 Dec 2019 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Code M | —5,000 | filing |
| 17 Dec 2018filed 18 Dec 2018 | NERV Minerva NeurosciencesBiotechnology | SEC FORM 4 Sold | $12K1,559 at $7.46 | filing |
News
Amarin (NASDAQ:AMRN) and Merck KGaA (OTCMKTS:MKKGY) Financial ReviewAMRN · themarketsdaily.com · 11 Oct 2026
0 headlines in the last 90 days name Frederick W. Ahlholm; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.